An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice
Status:
Not yet recruiting
Trial end date:
2027-04-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the safety, efficacy, quality of life, and biomarker
response in participants with moderate to severe ulcerative colitis in clinical practice.